News & Updates

Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
07 Oct 2021

In patients with acute coronary syndrome (ACS) or stable angina pectoris (SAP), undergoing noncardiac surgery after stenting increases the risk of myocardial infarction (MI), but only when procedures are performed during acute admission, a recent study has found.

Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
07 Oct 2021
CV safety of degarelix vs leuprolide: Results remain inconclusive
CV safety of degarelix vs leuprolide: Results remain inconclusive
06 Oct 2021 byRoshini Claire Anthony

In men with prostate cancer and concomitant atherosclerotic cardiovascular disease (ASCVD), major adverse cardiovascular event (MACE) incidence did not differ between those who were treated with degarelix or leuprolide, according to findings of the PRONOUNCE trial.

CV safety of degarelix vs leuprolide: Results remain inconclusive
06 Oct 2021
Is liraglutide cardioprotective in T2D patients?
Is liraglutide cardioprotective in T2D patients?
06 Oct 2021 byAudrey Abella

In individuals with type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonist (GLP1-RA) liraglutide appeared to yield a cardioprotective benefit, data from the secondary endpoint analysis of the LIRAFLAME* trial suggests.

Is liraglutide cardioprotective in T2D patients?
06 Oct 2021
Cardiac manifestations after COVID-19 jabs: When do they arise and who are at risk?
Cardiac manifestations after COVID-19 jabs: When do they arise and who are at risk?
06 Oct 2021 byTristan Manalac

Cardiac manifestations, such as acute myocardial infarction (AMI) and myocarditis, after vaccination for the coronavirus disease 2019 (COVID-19) are more common in men, according to a recent Singapore study. AMI is more likely to arise after the first shot, while myocarditis becomes more common after the second dose.

Cardiac manifestations after COVID-19 jabs: When do they arise and who are at risk?
06 Oct 2021
Menopausal hormone therapy a culprit in hypertension?
Menopausal hormone therapy a culprit in hypertension?
06 Oct 2021

Women on menopausal hormone therapy are at risk of developing hypertension, particularly those using oral oestrogen plus a progestogen such as pregnane and norpregnane derivatives, according to a study.

Menopausal hormone therapy a culprit in hypertension?
06 Oct 2021
Smoking ups venous thromboembolism risk in cancer patients
Smoking ups venous thromboembolism risk in cancer patients
05 Oct 2021

Smoking increases the risk of venous thromboembolism (VTE) in cancer patients, but not in people without cancer, a recent study has found.

Smoking ups venous thromboembolism risk in cancer patients
05 Oct 2021
Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers
Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers
05 Oct 2021 byJairia Dela Cruz

In the treatment of women with acute ischaemic stroke, mechanical thrombectomy is effective and can be safely performed during pregnancy or the postpartum period, as shown in a study.

Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers
05 Oct 2021